Procalcitonin Levels: Are Lumbar Punctures a Thing of the Past?
This module will look at current practices and the historical perspective of evaluating febrile infants less than sixty days of age. It will provide information on the incentives for limiting such evaluations and review common inflammatory markers. An overview of the PECARN study will be provided so the participant is better able to evaluate and understand the data related to the clinical prediction model for evaluating febrile infants.
Important: this continuing education activity is offered at a reduced rate to National Association of Pediatric Nurse Practitioners members. you must be logged in using your National Association of Pediatric Nurse Practitioners username and password to be recognized as a member of National Association of Pediatric Nurse Practitioners. If you are a current member of National Association of Pediatric Nurse Practitioners, and you are being asked to purchase this activity at the non-member rate, please contact the National Association of Pediatric Nurse Practitioners national office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org.
Copyright © 2020 by the National Association of Pediatric Nurse Practitioners.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners as an agency providing continuing education credit. individuals who complete this program and earn a 70% or higher score on the post tests will be awarded 0.75 National Association of Pediatric Nurse Practitioners contact hours.
Pediatric-focused advanced practice registered nurses.
•Define the role of procalcitonin in infection.
•Describe the epidemiology of bacteremia in the febrile infant.
•Identify current evidence-based practices for evaluating and treating the febrile infant.
•Discuss current practices among the participants and how procalcitonin is being used in their practice setting.
Chris Kyper, DNP, CPNP AC/PC
- 0.75 Contact hours